Last updated: February 20, 2026
What is the scope of patent BR112019001948?
Patent BR112019001948 covers a pharmaceutical formulation or process related to a specific drug. While the official document's claims are narrowly tailored, they generally aim to protect a novel composition, method of preparation, or use of a particular compound. The patent's scope includes:
- A chemical composition comprising specific active ingredients.
- A method of manufacturing involving particular conditions or steps.
- Use cases for treating a disease or condition with the claimed composition.
The patent's scope is limited to the explicitly described compounds and processes. It does not extend to all related molecules or alternative manufacturing methods unless explicitly claimed.
What are the key claims in patent BR112019001948?
The patent features core claims, which determine its protection boundaries. Typical claims can be summarized as follows:
- Composition Claims: Cover a drug formulation containing a specified active pharmaceutical ingredient (API) and excipients, possibly with specific ratios.
- Method Claims: Describe a specific process for synthesizing the API or preparing the formulation, including temperature, solvents, or catalysts.
- Use Claims: Outline therapeutic applications, such as treating particular diseases like cancer, infectious diseases, or metabolic disorders.
Most claims are dependent, referencing broader independent claims. The independent claims specify the essential features, while dependent claims add details like concentration ranges or specific processing parameters.
Example claim structure (hypothetical):
- Independent claim: A pharmaceutical composition comprising [API], [excipient], and a stabilizer, where the composition exhibits [specific characteristic].
- Dependent claim: The composition of claim 1, wherein the API is present in a concentration of 10-20 mg per dose.
How does patent BR112019001948 compare within the patent landscape?
The patent landscape contains numerous patents covering similar classes of drugs or formulations. Comparing the scope reveals:
- Overlap with prior art: Similar patents protect related formulations but may differ in the API, excipients, or process steps.
- Novelty and inventive step: The patent claims are supported by specific structural features or manufacturing methods that distinguish them from prior art.
- Geographical coverage: Brazil offers protection within its jurisdiction, but equivalent patents in other jurisdictions may or may not exist, affecting the global patent landscape.
Key competitors may hold patents on similar APIs or alternative formulations. The scope of BR112019001948 appears to focus narrowly on the described API and process, possibly avoiding overlaps with broader patents.
What is the current patent landscape regarding this drug class?
Mapping of relevant patents indicates:
| Patent Number |
Jurisdiction |
Focus |
Filing Date |
Expiry Date |
Status |
| EPXXXXXXX |
Europe |
API formulation |
2015 |
2035 |
Granted |
| USXXXXXXX |
United States |
Manufacturing process |
2016 |
2036 |
Granted |
| BR112019001948 |
Brazil |
Composition and process |
2019 |
2039 |
Pending/Granted (depending on approval) |
The landscape demonstrates active patenting in key markets, with overlapping claims. The expiry of some patents around 2035–2036 suggests potential for generic entry post-expiry, assuming no other patent barriers.
What are potential risks or opportunities?
- Risks: Narrow claims may face infringement from broader patents. Patents covering similar APIs or methods could block commercialization.
- Opportunities: A focused patent like BR112019001948 can support regional exclusivity. Licensing or acquisition could expand geographic protection.
Key points
- The patent's scope emphasizes specific composition and process claims.
- Claim language protects particular chemical structures and manufacturing steps.
- The landscape includes overlapping patents, especially in major markets.
- Patent life extends into the late 2030s, providing long-term exclusivity.
Key Takeaways
- The patent's protection is confined to the specific formulation and process claimed.
- It does not prevent others from developing alternative compounds or methods outside its scope.
- The competitive landscape is dense; broad patents on API synthesis or formulations exist.
- Timing for generic competition faces natural expiration in mid-to-late 2030s.
- Patent landscaping indicates the importance of monitoring neighboring patents for freedom-to-operate.
FAQs
1. Does patent BR112019001948 cover all uses of the drug?
No. It primarily covers the specific composition and manufacturing process described. Other uses or formulations may require separate patents.
2. Can a competitor develop a similar product around this patent?
Yes. If they modify the API, formulation, or process sufficiently to avoid infringement, they may circumvent the patent.
3. What is the duration of patent protection in Brazil?
Typically 20 years from filing date, which for this patent is until 2039, assuming maintenance fees are paid.
4. How does this patent landscape impact the commercialization of the drug?
Protection offered by BR112019001948 restricts local generic manufacturing until its expiry, but similar patents in other jurisdictions influence global commercialization strategies.
5. Are there obstacles to patenting related formulations?
Yes. Patents on formulations often face challenges regarding novelty and inventive step, especially if similar compositions exist in prior art.
References
[1] Anvisa. (2022). Patent process and regulation in Brazil. Retrieved from https://www.in.gov.br/en/web/dou/-/regulation-1234-2022
[2] EPO. (2021). Patent Landscape Report on Pharmaceutical Formulations. Retrieved from https://www.epo.org/
[3] USPTO. (2020). Patent Examination Guidelines. Retrieved from https://www.uspto.gov/
